AB
Anandvivek Bajpai
About Anandvivek Bajpai
Data last updated:
Anandvivek Bajpai is a Director at Kalysta Pharmaceuticals Private Limited (since 2014) and Director at Paris-Dakner Nanolifesciences Private Limited (since 2013). The companies operate in Pharma. The largest current company by reported revenue is Kalysta Pharmaceuticals Private Limited at ₹15.1 Lakh (FY 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kalysta Pharmaceuticals Private Limited U24230MH2014PTC260190 | Director | 16 Dec 2014 | 2014 | ₹15.1 Lakh (FY 2018) | Active |
| Paris-Dakner Nanolifesciences Private Limited U15323TN2009PTC072701 | Director | 14 Jun 2013 | 2009 | Active |
Board colleagues of Anandvivek Bajpai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gaytri Arun Singh | 06997701 | Kalysta Pharmaceuticals Private Limited | Director |
| Shailendra Kumar Dubey | 06363590 | Kalysta Pharmaceuticals Private Limited | Director |
| Kunasekaran Arun Pradeep | 06855567 | Paris-Dakner Nanolifesciences Private Limited | Additional Director |
| Mohanasundaram Umarani | 02027665 | Paris-Dakner Nanolifesciences Private Limited | Director |
| Mohanasundram Madhumathi | 01732696 | Paris-Dakner Nanolifesciences Private Limited | Additional Director |
| Sathish Kumar Muthupillai | 06796689 | Paris-Dakner Nanolifesciences Private Limited | Managing Director |
| Vignesh Mohanasundaram | 06855561 | Paris-Dakner Nanolifesciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anandvivek Bajpai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anandvivek Bajpai
Anandvivek Bajpai currently holds 2 directorships: Kalysta Pharmaceuticals Private Limited (Director, since 16 Dec 2014, revenue ₹15.1 Lakh (FY 2018)); Paris-Dakner Nanolifesciences Private Limited (Director, since 14 Jun 2013).
Anandvivek Bajpai was first appointed on 14 Jun 2013 as Director at Paris-Dakner Nanolifesciences Private Limited. The most recent appointment on record is 16 Dec 2014 at Kalysta Pharmaceuticals Private Limited.
The current boards of Anandvivek Bajpai's companies include Gaytri Arun Singh (Kalysta Pharmaceuticals Private Limited), Shailendra Kumar Dubey (Kalysta Pharmaceuticals Private Limited), Kunasekaran Arun Pradeep (Paris-Dakner Nanolifesciences Private Limited), Mohanasundaram Umarani (Paris-Dakner Nanolifesciences Private Limited), Mohanasundram Madhumathi (Paris-Dakner Nanolifesciences Private Limited), Sathish Kumar Muthupillai (Paris-Dakner Nanolifesciences Private Limited), among others.